Stockreport

ImmunityBio Reports Third-Quarter 2024 Financial Results

ImmunityBio, Inc.  (IBRX) 
PDF CULVER CITY, Calif.--(BUSINESS WIRE)--ImmunityBio, Inc. (NASDAQ: IBRX) today announced its financial results for the third-quarter ended September 30, 2024.ANKTIVA® [Read more]